Melphalan hydrochloride ( Alkeran®) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents. It is used primarily to treat multiple myeloma and ovarian cancer, and occasionally malignant melanoma. Otherwise known as L-Phenylalanine Mustard, or L-PAM, melphalan is a phenylalanine derivative of mechlorethamine. The agent was first investigated as a possible drug for use in melanoma. It did not work, but was found to be of use in myeloma.

404
Alkeran - Tablets and injection. Prescribing information for US residents in PDF format. [Acrobat Reader required]
Meta Description: [ About GSK summarizes the mission of GSK and provides users with an overview of the organization and biographies of our Board of Directors and Corporate Executive Team. ]
Alkeran - Product information from Glaxo Wellcome, in Portable Document Format (PDF). (melphalan)
Meta Description: [ This site serves as the homepage of GSK's corporate web site. ]
404
Alkeran - Prescribing information for UK residents in PDF format. [Acrobat Reader required]
Meta Description: [ About GSK summarizes the mission of GSK and provides users with an overview of the organization and biographies of our Board of Directors and Corporate Executive Team. ]
DrugDigest: Melphalan ( Alkeran, L-PAM ) - Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.
MEDLINEplus: Melphalan - Features information about dosage, usage, side effects, and warnings.
Meta Description: [ Melphalan (Systemic) ]
| ASH 2006 Dr. Palumbo discusses Velcade, Thalidomide Results | |
| Next Video | |